A detailed history of Susquehanna International Group, LLP transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Susquehanna International Group, LLP holds 205,800 shares of CORT stock, worth $10.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
205,800
Previous 6,454 3088.72%
Holding current value
$10.6 Million
Previous $209,000 4455.02%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$22.21 - $34.48 $607,732 - $943,476
-27,363 Reduced 80.91%
6,454 $209,000
Q1 2024

May 07, 2024

BUY
$21.1 - $27.46 $31,270 - $40,695
1,482 Added 4.58%
33,817 $851,000
Q4 2023

Feb 14, 2024

SELL
$24.82 - $32.88 $2.16 Million - $2.87 Million
-87,169 Reduced 72.94%
32,335 $1.05 Million
Q3 2023

Nov 14, 2023

BUY
$21.97 - $33.8 $1.14 Million - $1.75 Million
51,718 Added 76.3%
119,504 $3.26 Million
Q2 2023

Aug 11, 2023

BUY
$21.44 - $25.15 $345,033 - $404,738
16,093 Added 31.13%
67,786 $1.51 Million
Q1 2023

May 16, 2023

BUY
$19.2 - $24.47 $755,635 - $963,041
39,356 Added 319.01%
51,693 $1.12 Million
Q4 2022

Feb 14, 2023

SELL
$19.95 - $29.96 $575,557 - $864,346
-28,850 Reduced 70.05%
12,337 $250,000
Q3 2022

Nov 14, 2022

BUY
$24.7 - $29.12 $759,623 - $895,556
30,754 Added 294.78%
41,187 $1.06 Million
Q2 2022

Aug 15, 2022

SELL
$17.33 - $25.3 $700,443 - $1.02 Million
-40,418 Reduced 79.48%
10,433 $248,000
Q1 2022

May 16, 2022

SELL
$16.53 - $25.21 $163,746 - $249,730
-9,906 Reduced 16.3%
50,851 $1.15 Million
Q4 2021

Feb 14, 2022

BUY
$17.1 - $23.34 $546,806 - $746,343
31,977 Added 111.11%
60,757 $1.2 Million
Q2 2021

Aug 11, 2021

BUY
$19.97 - $24.43 $303,444 - $371,213
15,195 Added 111.85%
28,780 $633,000
Q1 2021

May 17, 2021

SELL
$23.49 - $30.56 $1 Million - $1.31 Million
-42,776 Reduced 75.9%
13,585 $323,000
Q4 2020

Feb 16, 2021

BUY
$16.78 - $27.3 $766,392 - $1.25 Million
45,673 Added 427.33%
56,361 $1.47 Million
Q3 2020

Nov 16, 2020

SELL
$12.46 - $19.98 $199,198 - $319,420
-15,987 Reduced 59.93%
10,688 $186,000
Q1 2020

May 15, 2020

SELL
$10.11 - $14.04 $228,324 - $317,079
-22,584 Reduced 45.85%
26,675 $317,000
Q3 2019

Nov 14, 2019

BUY
$10.41 - $14.66 $133,008 - $187,310
12,777 Added 35.02%
49,259 $696,000
Q2 2019

Aug 16, 2019

BUY
$9.78 - $12.76 $181,927 - $237,361
18,602 Added 104.04%
36,482 $407,000
Q1 2019

May 15, 2019

SELL
$10.03 - $15.71 $531,610 - $832,661
-53,002 Reduced 74.77%
17,880 $210,000
Q4 2018

Feb 14, 2019

BUY
$11.29 - $17.19 $510,443 - $777,194
45,212 Added 176.13%
70,882 $947,000
Q2 2018

Aug 14, 2018

SELL
$15.3 - $19.69 $644,252 - $829,106
-42,108 Reduced 62.13%
25,670 $404,000
Q3 2017

Nov 14, 2017

BUY
$12.3 - $19.3 $833,669 - $1.31 Million
67,778
67,778 $1.31 Million

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $5.51B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.